Specifically, compared to the non-stroke control cortex (Supplementary Figure S1A, top row), ET-1 injection caused significant tissue damage as revealed by immunostaining of NeuN, GFAP, and Iba1 at 3 weeks after focal ischemic stroke (Supplementary Figure S1A, bottom row). This evidence concerns the gene RBFOX3 and stroke disorder.